Industry News
Genetically low vitamin D levels linked to all-cause mortality
Nov 19, 2014
People with genetically low concentrations of vitamin D may be at increased risk of all-cause mortality, but not cardiovascular mortality, according to a new study. Read More
Hand soap antimicrobial linked to cancer and liver fibrosis
Nov 18, 2014
Researchers say an agent found in shampoo, hand soap and other personal hygiene products - triclosan - caused liver fibrosis and cancer in mice, and it could pose a risk to humans. Read More
New technology can detect bacterial invaders with unprecedented speed, sensitivity
Nov 18, 2014
A new bloodstream infection test created by UC Irvine researchers can speed up diagnosis times with unprecedented accuracy, allowing physicians to treat patients with potentially deadly ailments more... Read More
Melanoma shows improved regression with combination of PV-10 and checkpoint inhibitor
Nov 18, 2014
In a mouse model, PV-10 used alongside immune check point inhibitors improved melanoma regression and increased T cell activity, according to research presented at SITC's meeting. Read More
New strategy to reduce cancer impact, Australia
Nov 18, 2014
Cancer Australia has released its new Strategic Plan 2014-19, which articulates the importance of a strategic, nationally coordinated and evidence-based approach to address the current and future... Read More
Phase III trial of tumor treating fields in patients with newly diagnosed glioblastoma has been terminated at interim analysis due to early success
Nov 18, 2014
Novocure™, a commercial stage oncology company, announced today that Tumor Treating Fields (TTFields) delivered by the NovoTTF™-100A System in combination with standard-of-care... Read More
The secret life of anti-cancer drugs
Nov 18, 2014
The public is bombarded with news of exciting developments in cancer research every day, with new anti-cancer drugs greeted with excitement. But what happens to these drugs? Read More
Breast cancer; pooled analysis results of two Phase III Halaven® (eribulin) trials
Nov 18, 2014
The results from a pooled analysis of two Phase III Halaven(R) (eribulin) trials are published in Breast Cancer Research and Treatment. Read More
In prostate cancer patients carrying 'BRCA' mutations, conventional therapies are less efficient
Nov 18, 2014
Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to conventional treatment, including surgery and/or radiotherapy - and they also have a lower survival rate... Read More
Among other health benefits walnuts slow prostate cancer growth
Nov 18, 2014
Researchers at UC Davis and other institutions have found that diets rich in whole walnuts or walnut oil slowed prostate cancer growth in mice. Read More
Previous Page Next Page